Insider Transactions in Q4 2020 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 04
2020
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
62
-0.99%
|
$9,424
$152.55 P/Share
|
Dec 03
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
250
-0.08%
|
$37,500
$150.0 P/Share
|
Dec 01
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.3%
|
$140,000
$140.58 P/Share
|
Nov 12
2020
|
Patrick G Enright Director |
SELL
Open market or private sale
|
Direct |
9,929
-12.26%
|
$1,449,634
$146.81 P/Share
|
Nov 06
2020
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
197
-1.39%
|
$29,747
$151.93 P/Share
|
Nov 05
2020
|
Kenneth W O'Keefe Director |
SELL
Open market or private sale
|
Direct |
11,000
-10.78%
|
$1,694,000
$154.47 P/Share
|
Nov 04
2020
|
Catherine A. Sohn Director |
SELL
Open market or private sale
|
Direct |
12,500
-36.36%
|
$1,925,000
$154.0 P/Share
|
Nov 04
2020
|
Catherine A. Sohn Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+26.49%
|
$800,000
$64.3 P/Share
|
Nov 04
2020
|
Paul L Berns Director |
SELL
Open market or private sale
|
Direct |
4,691
-11.43%
|
$698,959
$149.21 P/Share
|
Nov 03
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,500
-0.75%
|
$385,000
$154.0 P/Share
|
Nov 02
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.3%
|
$145,000
$145.13 P/Share
|
Nov 02
2020
|
Patrick G Enright Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,929
+24.68%
|
-
|
Nov 02
2020
|
Kenneth W O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
22,249
+42.86%
|
-
|
Nov 02
2020
|
Paul L Berns Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,691
+24.53%
|
-
|
Oct 01
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
4,500
-1.34%
|
$634,500
$141.94 P/Share
|